Santos da Silva Jorge's Form 4 filing
MoonLake Immunotherapeutics (MLTX) · filed Jul 2, 2026
- Accession no.
- 0001213900-26-074964
- Filed
- Jul 2, 2026, 4:10 PM ET
- Trade date
- Jul 1, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $956.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Santos da Silva JorgeCIK 0001920509 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −47,775 | $20.03 | −$956,933.25 | 2,877,118 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.